#CGTX

How does Lecanemab compare to other Alzheimer's assets?

Summary: Biogen and Eisai's asset Lecanemab has a PDUFA date set for Friday 1/6/23 Lecanemab targets and effectively reduces beta-amyloid...

Jan 4, 2023

Summary:

Jan 4, 2023

$XBI $80.99 | +5.81% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates # Pipeline Updates #LXRX +41.8%...

Jul 5, 2022

$XBI $80.99 | +5.81% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates # Pipeline Updates #LXRX +41.8%...

Jul 5, 2022

$XBI $74.80 | +1.0% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +1.6% Novavax COVID-19 Data...

Jun 29, 2022

$XBI $74.80 | +1.0% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +1.6% Novavax COVID-19 Data...

Jun 29, 2022

Our platform helps you uncover your next biotech investment opportunity